The Musculoskeletal Disorders Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Musculoskeletal Disorders Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Musculoskeletal Disorders Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Musculoskeletal Disorders Therapeutics Market Report

Report Metric	Details
Report Name	Musculoskeletal Disorders Therapeutics Market
Segment by Type	Biologics Small Molecules
Segment by Application	Osteoarthritis Osteoporosis Psoriatic Arthritis Ankylosing Spondylitis Fibromyalgia
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Johnson & Johnson, Amgen, Pfizer, F. Hoffmann-La Roche, Eli Lilly, Merck, Novartis, AstraZeneca, Astellas, AB Sciences, 3SBio, Samsung Bioepis, Sanofi, Taisho Pharmaceutical, Takeda, Zosano Pharma, LG Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Musculoskeletal Disorders Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Musculoskeletal Disorders Therapeutics Market report?

Ans: The main players in the Musculoskeletal Disorders Therapeutics Market are AbbVie, Johnson & Johnson, Amgen, Pfizer, F. Hoffmann-La Roche, Eli Lilly, Merck, Novartis, AstraZeneca, Astellas, AB Sciences, 3SBio, Samsung Bioepis, Sanofi, Taisho Pharmaceutical, Takeda, Zosano Pharma, LG Life Sciences

What are the Application segmentation covered in the Musculoskeletal Disorders Therapeutics Market report?

Ans: The Applications covered in the Musculoskeletal Disorders Therapeutics Market report are Osteoarthritis, Osteoporosis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia

What are the Type segmentation covered in the Musculoskeletal Disorders Therapeutics Market report?

Ans: The Types covered in the Musculoskeletal Disorders Therapeutics Market report are Biologics, Small Molecules

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Biologics

1.2.3 Small Molecules

1.3 Market by Application

1.3.1 Global Musculoskeletal Disorders Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Osteoarthritis

1.3.3 Osteoporosis

1.3.4 Psoriatic Arthritis

1.3.5 Ankylosing Spondylitis

1.3.6 Fibromyalgia

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Musculoskeletal Disorders Therapeutics Market Perspective (2019-2030)

2.2 Musculoskeletal Disorders Therapeutics Growth Trends by Region

2.2.1 Global Musculoskeletal Disorders Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Musculoskeletal Disorders Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Musculoskeletal Disorders Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Musculoskeletal Disorders Therapeutics Market Dynamics

2.3.1 Musculoskeletal Disorders Therapeutics Industry Trends

2.3.2 Musculoskeletal Disorders Therapeutics Market Drivers

2.3.3 Musculoskeletal Disorders Therapeutics Market Challenges

2.3.4 Musculoskeletal Disorders Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Musculoskeletal Disorders Therapeutics Players by Revenue

3.1.1 Global Top Musculoskeletal Disorders Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Musculoskeletal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Musculoskeletal Disorders Therapeutics Revenue

3.4 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio

3.4.1 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal Disorders Therapeutics Revenue in 2023

3.5 Musculoskeletal Disorders Therapeutics Key Players Head office and Area Served

3.6 Key Players Musculoskeletal Disorders Therapeutics Product Solution and Service

3.7 Date of Enter into Musculoskeletal Disorders Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Musculoskeletal Disorders Therapeutics Breakdown Data by Type

4.1 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Type (2025-2030)

5 Musculoskeletal Disorders Therapeutics Breakdown Data by Application

5.1 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Musculoskeletal Disorders Therapeutics Market Size (2019-2030)

6.2 North America Musculoskeletal Disorders Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Musculoskeletal Disorders Therapeutics Market Size by Country (2019-2024)

6.4 North America Musculoskeletal Disorders Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Musculoskeletal Disorders Therapeutics Market Size (2019-2030)

7.2 Europe Musculoskeletal Disorders Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2019-2024)

7.4 Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Musculoskeletal Disorders Therapeutics Market Size (2019-2030)

9.2 Latin America Musculoskeletal Disorders Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Detail

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Musculoskeletal Disorders Therapeutics Introduction

11.1.4 AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.1.5 AbbVie Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Musculoskeletal Disorders Therapeutics Introduction

11.2.4 Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.2.5 Johnson & Johnson Recent Development

11.3 Amgen

11.3.1 Amgen Company Detail

11.3.2 Amgen Business Overview

11.3.3 Amgen Musculoskeletal Disorders Therapeutics Introduction

11.3.4 Amgen Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.3.5 Amgen Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Detail

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Musculoskeletal Disorders Therapeutics Introduction

11.4.4 Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.4.5 Pfizer Recent Development

11.5 F. Hoffmann-La Roche

11.5.1 F. Hoffmann-La Roche Company Detail

11.5.2 F. Hoffmann-La Roche Business Overview

11.5.3 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Introduction

11.5.4 F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.5.5 F. Hoffmann-La Roche Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Detail

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Musculoskeletal Disorders Therapeutics Introduction

11.6.4 Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.6.5 Eli Lilly Recent Development

11.7 Merck

11.7.1 Merck Company Detail

11.7.2 Merck Business Overview

11.7.3 Merck Musculoskeletal Disorders Therapeutics Introduction

11.7.4 Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.7.5 Merck Recent Development

11.8 Novartis

11.8.1 Novartis Company Detail

11.8.2 Novartis Business Overview

11.8.3 Novartis Musculoskeletal Disorders Therapeutics Introduction

11.8.4 Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.8.5 Novartis Recent Development

11.9 AstraZeneca

11.9.1 AstraZeneca Company Detail

11.9.2 AstraZeneca Business Overview

11.9.3 AstraZeneca Musculoskeletal Disorders Therapeutics Introduction

11.9.4 AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.9.5 AstraZeneca Recent Development

11.10 Astellas

11.10.1 Astellas Company Detail

11.10.2 Astellas Business Overview

11.10.3 Astellas Musculoskeletal Disorders Therapeutics Introduction

11.10.4 Astellas Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.10.5 Astellas Recent Development

11.11 AB Sciences

11.11.1 AB Sciences Company Detail

11.11.2 AB Sciences Business Overview

11.11.3 AB Sciences Musculoskeletal Disorders Therapeutics Introduction

11.11.4 AB Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.11.5 AB Sciences Recent Development

11.12 3SBio

11.12.1 3SBio Company Detail

11.12.2 3SBio Business Overview

11.12.3 3SBio Musculoskeletal Disorders Therapeutics Introduction

11.12.4 3SBio Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.12.5 3SBio Recent Development

11.13 Samsung Bioepis

11.13.1 Samsung Bioepis Company Detail

11.13.2 Samsung Bioepis Business Overview

11.13.3 Samsung Bioepis Musculoskeletal Disorders Therapeutics Introduction

11.13.4 Samsung Bioepis Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.13.5 Samsung Bioepis Recent Development

11.14 Sanofi

11.14.1 Sanofi Company Detail

11.14.2 Sanofi Business Overview

11.14.3 Sanofi Musculoskeletal Disorders Therapeutics Introduction

11.14.4 Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.14.5 Sanofi Recent Development

11.15 Taisho Pharmaceutical

11.15.1 Taisho Pharmaceutical Company Detail

11.15.2 Taisho Pharmaceutical Business Overview

11.15.3 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Introduction

11.15.4 Taisho Pharmaceutical Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.15.5 Taisho Pharmaceutical Recent Development

11.16 Takeda

11.16.1 Takeda Company Detail

11.16.2 Takeda Business Overview

11.16.3 Takeda Musculoskeletal Disorders Therapeutics Introduction

11.16.4 Takeda Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.16.5 Takeda Recent Development

11.17 Zosano Pharma

11.17.1 Zosano Pharma Company Detail

11.17.2 Zosano Pharma Business Overview

11.17.3 Zosano Pharma Musculoskeletal Disorders Therapeutics Introduction

11.17.4 Zosano Pharma Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.17.5 Zosano Pharma Recent Development

11.18 LG Life Sciences

11.18.1 LG Life Sciences Company Detail

11.18.2 LG Life Sciences Business Overview

11.18.3 LG Life Sciences Musculoskeletal Disorders Therapeutics Introduction

11.18.4 LG Life Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024)

11.18.5 LG Life Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Taisho Pharmaceutical

Takeda

Zosano Pharma

LG Life Sciences

List of Tables

Table 1. Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Biologics

Table 3. Key Players of Small Molecules

Table 4. Global Musculoskeletal Disorders Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Musculoskeletal Disorders Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Musculoskeletal Disorders Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Musculoskeletal Disorders Therapeutics Market Share by Region (2019-2024)

Table 8. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Musculoskeletal Disorders Therapeutics Market Share by Region (2025-2030)

Table 10. Musculoskeletal Disorders Therapeutics Market Trends

Table 11. Musculoskeletal Disorders Therapeutics Market Drivers

Table 12. Musculoskeletal Disorders Therapeutics Market Challenges

Table 13. Musculoskeletal Disorders Therapeutics Market Restraints

Table 14. Global Musculoskeletal Disorders Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Musculoskeletal Disorders Therapeutics Market Share by Players (2019-2024)

Table 16. Global Top Musculoskeletal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2023)

Table 17. Ranking of Global Top Musculoskeletal Disorders Therapeutics Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Musculoskeletal Disorders Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Musculoskeletal Disorders Therapeutics Product Solution and Service

Table 21. Date of Enter into Musculoskeletal Disorders Therapeutics Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Musculoskeletal Disorders Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2019-2024)

Table 25. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2025-2030)

Table 27. Global Musculoskeletal Disorders Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Application (2019-2024)

Table 29. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Application (2025-2030)

Table 31. North America Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Musculoskeletal Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Musculoskeletal Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. AbbVie Company Detail

Table 47. AbbVie Business Overview

Table 48. AbbVie Musculoskeletal Disorders Therapeutics Product

Table 49. AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 50. AbbVie Recent Development

Table 51. Johnson & Johnson Company Detail

Table 52. Johnson & Johnson Business Overview

Table 53. Johnson & Johnson Musculoskeletal Disorders Therapeutics Product

Table 54. Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 55. Johnson & Johnson Recent Development

Table 56. Amgen Company Detail

Table 57. Amgen Business Overview

Table 58. Amgen Musculoskeletal Disorders Therapeutics Product

Table 59. Amgen Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 60. Amgen Recent Development

Table 61. Pfizer Company Detail

Table 62. Pfizer Business Overview

Table 63. Pfizer Musculoskeletal Disorders Therapeutics Product

Table 64. Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 65. Pfizer Recent Development

Table 66. F. Hoffmann-La Roche Company Detail

Table 67. F. Hoffmann-La Roche Business Overview

Table 68. F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Product

Table 69. F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 70. F. Hoffmann-La Roche Recent Development

Table 71. Eli Lilly Company Detail

Table 72. Eli Lilly Business Overview

Table 73. Eli Lilly Musculoskeletal Disorders Therapeutics Product

Table 74. Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 75. Eli Lilly Recent Development

Table 76. Merck Company Detail

Table 77. Merck Business Overview

Table 78. Merck Musculoskeletal Disorders Therapeutics Product

Table 79. Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 80. Merck Recent Development

Table 81. Novartis Company Detail

Table 82. Novartis Business Overview

Table 83. Novartis Musculoskeletal Disorders Therapeutics Product

Table 84. Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 85. Novartis Recent Development

Table 86. AstraZeneca Company Detail

Table 87. AstraZeneca Business Overview

Table 88. AstraZeneca Musculoskeletal Disorders Therapeutics Product

Table 89. AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 90. AstraZeneca Recent Development

Table 91. Astellas Company Detail

Table 92. Astellas Business Overview

Table 93. Astellas Musculoskeletal Disorders Therapeutics Product

Table 94. Astellas Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 95. Astellas Recent Development

Table 96. AB Sciences Company Detail

Table 97. AB Sciences Business Overview

Table 98. AB Sciences Musculoskeletal Disorders Therapeutics Product

Table 99. AB Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 100. AB Sciences Recent Development

Table 101. 3SBio Company Detail

Table 102. 3SBio Business Overview

Table 103. 3SBio Musculoskeletal Disorders Therapeutics Product

Table 104. 3SBio Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 105. 3SBio Recent Development

Table 106. Samsung Bioepis Company Detail

Table 107. Samsung Bioepis Business Overview

Table 108. Samsung Bioepis Musculoskeletal Disorders Therapeutics Product

Table 109. Samsung Bioepis Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 110. Samsung Bioepis Recent Development

Table 111. Sanofi Company Detail

Table 112. Sanofi Business Overview

Table 113. Sanofi Musculoskeletal Disorders Therapeutics Product

Table 114. Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 115. Sanofi Recent Development

Table 116. Taisho Pharmaceutical Company Detail

Table 117. Taisho Pharmaceutical Business Overview

Table 118. Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Product

Table 119. Taisho Pharmaceutical Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 120. Taisho Pharmaceutical Recent Development

Table 121. Takeda Company Detail

Table 122. Takeda Business Overview

Table 123. Takeda Musculoskeletal Disorders Therapeutics Product

Table 124. Takeda Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 125. Takeda Recent Development

Table 126. Zosano Pharma Company Detail

Table 127. Zosano Pharma Business Overview

Table 128. Zosano Pharma Musculoskeletal Disorders Therapeutics Product

Table 129. Zosano Pharma Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 130. Zosano Pharma Recent Development

Table 131. LG Life Sciences Company Detail

Table 132. LG Life Sciences Business Overview

Table 133. LG Life Sciences Musculoskeletal Disorders Therapeutics Product

Table 134. LG Life Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2019-2024) & (US$ Million)

Table 135. LG Life Sciences Recent Development

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Musculoskeletal Disorders Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Musculoskeletal Disorders Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Biologics Features

Figure 4. Small Molecules Features

Figure 5. Global Musculoskeletal Disorders Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Musculoskeletal Disorders Therapeutics Market Share by Application: 2023 VS 2030

Figure 7. Osteoarthritis Case Studies

Figure 8. Osteoporosis Case Studies

Figure 9. Psoriatic Arthritis Case Studies

Figure 10. Ankylosing Spondylitis Case Studies

Figure 11. Fibromyalgia Case Studies

Figure 12. Musculoskeletal Disorders Therapeutics Report Years Considered

Figure 13. Global Musculoskeletal Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Musculoskeletal Disorders Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Musculoskeletal Disorders Therapeutics Market Share by Region: 2023 VS 2030

Figure 16. Global Musculoskeletal Disorders Therapeutics Market Share by Players in 2023

Figure 17. Global Top Musculoskeletal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Musculoskeletal Disorders Therapeutics Revenue in 2023

Figure 19. North America Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Musculoskeletal Disorders Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Musculoskeletal Disorders Therapeutics Market Share by Country (2019-2030)

Figure 25. Germany Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Share by Region (2019-2030)

Figure 33. China Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Musculoskeletal Disorders Therapeutics Market Share by Country (2019-2030)

Figure 41. Mexico Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Share by Country (2019-2030)

Figure 45. Turkey Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. AbbVie Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 48. Johnson & Johnson Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 49. Amgen Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 50. Pfizer Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 51. F. Hoffmann-La Roche Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 52. Eli Lilly Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 53. Merck Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 54. Novartis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 55. AstraZeneca Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 56. Astellas Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 57. AB Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 58. 3SBio Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 59. Samsung Bioepis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 60. Sanofi Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 61. Taisho Pharmaceutical Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 62. Takeda Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 63. Zosano Pharma Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 64. LG Life Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions